Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5406-5414
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5406
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5406
Characteristic | n | DFS | OS | ||||||
HR (95%CI)1 | P value1 | HR (95%CI)2 | P value2 | HR (95%CI)1 | P value1 | HR (95%CI)2 | P value2 | ||
Age | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |||||
< 60 yr | 792 | 1 | 1 | 1 | 1 | ||||
≥ 60 yr | 772 | 1.58 (1.35-1.85) | 1.42 (1.18-1.71) | 1.60 (1.35-1.89) | 1.39 (1.15-1.70) | ||||
Gender | 0.674 | 0.992 | 0.976 | 0.651 | |||||
Female | 387 | 1 | 1 | 1 | 1 | ||||
Male | 1177 | 0.96 (0.80-1.15) | 1.00 (0.82-1.23) | 1.00 (0.82-1.21) | 1.05 (0.85-1.30) | ||||
Minority | 0.364 | 0.600 | 0.563 | 0.797 | |||||
Han population | 1507 | 1 | 1 | 1 | 1 | ||||
Others | 57 | 0.81 (0.51-1.28) | 0.87 (0.52-1.46) | 0.87 (0.54-1.40) | 0.93 (0.55-1.59) | ||||
History of familial cancer | 0.367 | 0.295 | 0.610 | 0.523 | |||||
No | 1157 | 1 | 1 | 1 | 1 | ||||
Yes | 157 | 1.12 (0.87-1.44) | 1.15 (0.89-1.48) | 1.07 (0.82-1.41) | 1.09 (0.83-1.44) | ||||
Tumor location | < 0.001 | 0.743 | 0.003 | 0.545 | |||||
Cardia | 1007 | 1 | 1 | 1 | 1 | ||||
Non-cardia | 557 | 1.34 (1.14-1.57) | 0.97 (0.81-1.16) | 1.29 (1.09-1.53) | 0.94 (0.78-1.14) | ||||
TNM stage | |||||||||
I | 376 | 1 | 1 | 1 | |||||
II | 329 | 2.71 (1.92-3.83) | < 0.001 | 2.61 (1.76-3.87) | < 0.001 | 3.27 (2.21-4.83) | < 0.001 | 3.33 (2.14-5.18) | < 0.001 |
III | 859 | 6.25 (4.64-8.44) | < 0.001 | 6.50 (4.57-9.23) | < 0.001 | 7.58 (5.37-10.70) | < 0.001 | 8.70 (5.83-12.98) | < 0.001 |
Tumor embolus | < 0.001 | 0.339 | < 0.001 | 0.802 | |||||
No | 1175 | 1 | 1 | 1 | 1 | ||||
Yes | 289 | 1.81 (1.53-2.13) | 1.10 (0.90-1.34) | 1.70 (1.43-2.03) | 0.97 (0.79-1.20) | ||||
Neural invasion | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |||||
No | 1334 | 1 | 1 | 1 | 1 | ||||
Yes | 230 | 1.90 (1.57-2.30) | 1.51 (1.21-1.89) | 2.06 (1.69-2.52) | 1.68 (1.33-2.12) | ||||
Adjuvant chemotherapy | 0.008 | 0.0151 | 0.052 | 0.002 | |||||
No | 678 | 1 | 1 | 1 | 1 | ||||
Yes | 886 | 1.24 (1.06-1.47) | 0.79 (0.65-0.95) | 1.19 (1.00-1.40) | 0.73 (0.60-0.90) | ||||
Adjuvant radiotherapy | 0.008 | 0.478 | 0.254 | 0.667 | |||||
No | 1462 | 1 | 1 | 1 | 1 | ||||
Yes | 102 | 1.46 (1.10-1.93) | 1.11 (0.83-1.49) | 1.20 (0.88-1.64) | 0.93 (0.67-1.29) | ||||
HER2 | 0.561 | 0.105 | 0.898 | 0.118 | |||||
Negative (-) | 1015 | 1 | 1 | 1 | 1 | ||||
Positive (+) | 549 | 0.95 (0.81-1.12) | 1.19 (0.96-1.46) | 0.99 (0.83-1.18) | 1.19 (0.96-1.48) |
- Citation: Shen GS, Zhao JD, Zhao JH, Ma XF, Du F, Kan J, Ji FX, Ma F, Zheng FC, Wang ZY, Xu BH. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China. World J Gastroenterol 2016; 22(23): 5406-5414
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5406.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5406